Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | -1391.91% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -1504.23% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -2380.51% | +0.00% | -15349.58% |
| EPS Growth | +0.00% | +0.00% | -1635.27% | +0.00% | -8838.74% |
| EPS Diluted Growth | +0.00% | +0.00% | -1701.73% | +0.00% | -9165.42% |
| Weighted Average Shares Growth | +16.14% | -0.02% | +58.73% | +60.60% | +73.90% |
| Weighted Average Shares Diluted Growth | +20.99% | +4.15% | +52.37% | +54.18% | +66.94% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -1559.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -1559.00% | +0.00% | +0.00% |
| Receivables Growth | +48.80% | -57.78% | +1481.77% | +722.46% | +650.03% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +747.95% | +764.61% | +736.23% | +1282.92% | +55.62% |
| Book Value per Share Growth | +725.30% | +880.64% | +435.37% | +822.73% | -11.22% |
| Debt Growth | +234.90% | +379.66% | +906.21% | +5.73% | -42.59% |
| R&D Expense Growth | -14.70% | +2336.85% | +0.00% | +1049.90% | +441.50% |
| SG&A Expenses Growth | +34.83% | +85.97% | +84.61% | +115.49% | +101.36% |